To access this material please log in or register

Register Authorize

Choice between conservative and invasive approach at stable coronary heart disease

Berstein L. L., Katamadze N. O., Andreeva A. E., Laznam S. S., Grishkin Yu. N.

Keywords: conservative treatment , stable CHD, surgical therapy

DOI: 10.18087/rhj.2013.2.1755

Modern approach to treatment of stable CHD consists in administration of optimal drug therapy, which in some patients, can be supplemented by revasculization in the form of operation of coronary bypass surgery or transcutaneous coronary intervention. Guidelines on reasonability of coronary revasculization, made by cardiological and cardiosurgical associations, specify that coronary revasculization is reasonable, when its benefits concerning indices of quality of life (symptoms, functional condition, etc.) prognosis exceed possible adverse consequences of the procedure. Meanwhile, if a patient has no severe anginal pains, it is rather difficult to decide who needs revasculization and who will not benefit from it. This review discusses principles of selection of treatment approach at stable CHD, based on materials of available guidelines and clinical studies.
  1. European Association for Percutaneous Cardiovascular Interventions. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010 Oct;31 (20):2501–2555.
  2. Patel MR, Dehmer GJ, Hirshfeld JW et al. ACCF / SCAI / STS / AATS / AHA / ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2009;53 (6):530–553.
  3. Eagle KA, Guyton RA, Davidoff R et al. ACC / AHA Guidelines for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). American College of Cardiology / American Heart Association. J Am Coll Cardiol. 1999;34 (4):1262–1347.
  4. Акчурин Р. С., Васюк Ю. А., Карпов Ю. А. с др. Национальные рекомендации по диагностике и лечению стабильной стенокардии. 2008 г. Кардиоваскулярная терапия и профилактика 2008;7 (6) (приложение 4):40с.
  5. Califf RM, Armstrong PW, Carver JR et al. Task Force 5: Stratification of patients into high, medium and low subgroups for purposes of risk factor management. J Am Coll Cardiol. 1996;27 (5):964–1047.
  6. Yusuf S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft syrgery on survival. Overview of 10‑year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344 (8922):563–570.
  7. Gibbons RJ, Abrams J, Chatterjee K et al. ACC / AHA 2002 guideline update for the management of patients with chronic stable angina – summary article: a report of the American College of Cardiology / American Heart Association Task Force on practice guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol. 2003;41 (1):159–168.
  8. Sianos G, Morel MA, Kappetein AP et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1 (2):219–227.
  9. Girasis C, Garg S, Räber L et al. SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-elu­ting stent for coronary revascularization (SIRTAX) trial. Eur Heart J. 2011;32 (24):3115–3127.
  10. Emond M, Mock MB, Davis KB et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90 (6):2645–2657.
  11. Hillis LD, Smith PK, Anderson JL et al. 2011 ACCF / AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124 (23):e652–735.
  12. Topkara VK, Cheema FH, Kesavaramanujam S et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation. 2005;112 (9 Suppl): I344‑I350.
  13. Bonow RO, Maurer G, Lee KL et al. STICH Trial Investigators. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364 (17):1617–1625.
  14. Лупанов В. П. Современные функциональные методы исследования сердечно-сосудистой системы в диагностике, оценке тяжести и прогнозе больных ишемической болезнью сердца. Кардиоваскулярная терапия и профилактика 2011;10 (5):106–115.
  15. Беленков Ю. Н., Оганов Р. Г. Кардиология. Национальное руководство. – М.: ГЭОТАР-Медиа, 2010. – c 147–160.
  16. Mark DB, Shaw L, Harrell FE Jr et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med. 1991;325 (12):849–853.
  17. Jadvar H, Strauss HW, Segall GM. SPECT and PET in the Evaluation of Coronary Artery Disease. Radiographics. 1999;19 (4):915–926.
  18. Sicari R, Nihoyannopoulos P, Evangelista A et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008;9 (4):415–437.
  19. Берштейн Л. Л., Гришкин Ю. Н. Жизнеспособный миокард при хроническом нарушении регионарной сократимости левого желудочка у больных ИБС. Российский кардиологический журнал. 1998;2 (3):3–9.
  20. Camici PG, Rimoldi O. Myocardial hibernation vs repetitive stunning in patients. Cardiol Rev. 1999;7 (1):39–43.
  21. Саидова М. А. Современные методы диагностики жизнеспособного миокарда. Кардиология 2005;45 (9):47–54.
  22. Schinkel AFL, Poldermans D, Elhendy A, Bax JJ. Assessment of myocardial viability in patients with heart failure. J Nucl Med 2007;48 (7):1135–1146.
  23. Boden WE, O'Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356 (15):1503–1516.
  24. Честухин В. В., Миронков Б. Л., Рядовой И. Г. и др. Сравнение эффективности чрескожных коронарных вмешательств и оптимальной медикаментозной терапии в лечении стабильной формы коронарной болезни сердца. Взгляд интервенционного кардиолога на проблему и результаты исследования COURAGE. Сердце 2007;6 (5):265–268.
  25. Koo BK, Erglis A, Doh JH et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms results from the Prospective Multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol. 2011;58 (19):1989–1997.
  26. Мовсесянц М. Ю., Покатилов А. А., Прямиков А. Д. и др. Измерение фракционного резерва кровотока при поражении коронарных артерий. Сердце 2012;9 (3):145–149.
  27. Pijls NH, Fearon WF, Tonino PA et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2‑year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol. 2010;56 (3):177–184.
  28. Hachamovitch R, Hayes SW, Friedman JD et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107 (23):2900–2907.
  29. Bruyne BD, Pijls NH, Kalesan B et al. Fractional Flow Reserve – Guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367 (11):991–1001.
Berstein L. L., Katamadze N. O., Andreeva A. E. et al. Choice between conservative and invasive approach at stable coronary heart disease. Russian Heart Journal. 2013;12(2):93-101

To access this material please log in or register

Register Authorize
Ru En